Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda Faces First Trial Over Actos Diabetes Drug in L.A.
Bloomberg
Tue, 02/19/13 - 10:11 am
Takeda
Actos
diabetes
Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek
Sat, 02/16/13 - 12:23 pm
type 2 diabetes
Takeda
diabetes
cancer
Actos
Furiex Rises on FDA Approval of Takeda Diabetes Medicine
Bloomberg
Mon, 01/28/13 - 10:47 am
FDA
diabetes
Takeda
Furiex Pharmaceuticals
alogliptin
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Mon, 01/28/13 - 10:11 am
Takeda
diabetes
Actos
FDA
FDA announces approval of three new drugs to treat Type 2 diabetes
examiner.com
Sun, 01/27/13 - 11:35 am
type 2 diabetes
Takeda
diabetes
alogliptin
Furiex Pharmaceuticals
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Sun, 01/27/13 - 11:25 am
Takeda
diabetes
type 2 diabetes
Actos
alogliptin
Furiex Pharmaceuticals
Affymax: Investor Darling In 2012 Now Has To Perform In 2013
Seeking Alpha
Mon, 01/21/13 - 11:42 am
Takeda
Fresenius
Amgen
Affymax
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
Takeda and Amylin terminate obesity compound co-development agreement
equities.com
Sat, 12/29/12 - 10:38 am
Takeda
Amylin
obesity
weight loss
Takeda writes off its $1B obesity deal with Amylin
Fierce Biotech
Fri, 12/28/12 - 11:59 am
Amylin
Takeda
Takeda Consultant Loses Two Whistleblower Suits
Pharmalot
Tue, 11/20/12 - 11:29 am
Takeda
whistleblower lawsuits
Takeda to acquire Envoy in $140 million deal
Pharma Times, UK
Tue, 11/6/12 - 12:12 pm
Takeda
Envoy Therapeutics
M&A
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Takeda to buy LigoCyte, signs pact with India's Advinus
Pharma Times, UK
Fri, 10/5/12 - 12:22 pm
Takeda
LigoCyte
India
M&A
Advinus
Lundbeck, Takeda seek U.S. approval for antidepressant
Chicago Tribune, IL
Tue, 10/2/12 - 12:17 pm
Takeda
Lundbeck
antidepressants
vortioxetine
Cashed Up Biotech Vanda Could Keep On Falling
Seeking Alpha
Wed, 09/5/12 - 10:44 am
Vanda
Eli Lilly
Novartis
Bristol-Myers Squibb
Takeda
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tue, 08/28/12 - 10:54 am
Merck
Januvia
diabetes
AstraZeneca
Bristol-Myers Squibb
JNJ
Novartis
Sanofi
Takeda
Takeda's Actos era ends with generic launches
Fierce Pharma
Sat, 08/18/12 - 04:02 pm
Takeda
Actos
diabetes
type 2 diabetes
generics
Teva and Ranbaxy start selling lower-cost version of Takeda's type 2 diabetes drug Actos
Yahoo/AP
Fri, 08/17/12 - 11:54 am
Teva Pharmaceuticals
Takeda
Ranbaxy
generics
diabetes
Actos
Watson sues FDA on generic diabetes drug ruling
Yahoo/Reuters
Wed, 08/15/12 - 11:10 am
FDA
generics
Watson Pharmaceuticals
diabetes
Actos
Takeda
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »